person · Reporting owner
Linthwaite Stephen Christopher
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.FLDM · Entity 6116 | President & CEO | February 22, 2022 | February 24, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date February 22, 2022 · Filed February 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 326,334 |
Reported balance
After 2022-02-22 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-02-22 · Exercise / conversion · Acquired 7,813 · Balance 326,334 F1: Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 333,216 |
Reported balance
After 2022-02-22 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2022-02-22 · Exercise / conversion · Acquired 6,882 · Balance 333,216 |
| Common StockSEC Table I · non-derivative | Direct | 340,938 |
Reported balance
After 2022-02-22 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2022-02-22 · Exercise / conversion · Acquired 7,722 · Balance 340,938 |
| Common StockSEC Table I · non-derivative | Direct | 328,473 |
Reported balance
After 2022-02-22 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2022-02-22 · Tax withholding · Disposed 12,465 · Balance 328,473 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,813 |
Reported balance
After 2022-02-22 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-02-22 · Exercise / conversion · Disposed 7,813 · Balance 7,813 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 27,528 |
Reported balance
After 2022-02-22 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-02-22 · Exercise / conversion · Disposed 6,882 · Balance 27,528 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 61,779 |
Reported balance
After 2022-02-22 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-02-22 · Exercise / conversion · Disposed 7,722 · Balance 61,779 F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock.
F3: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter.
F4: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
F5: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2022 Filed Feb 24, 2022 22:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000014 · wf-form4_164574099142402.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,779 Underlying: Common Stock · 7,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000014 · wf-form4_164574099142402.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,528 Underlying: Common Stock · 6,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000014 · wf-form4_164574099142402.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,813 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 12,465 | $3.62 | $45,123.30 |
DisclosureSEC source: 0001162194-22-000014 · wf-form4_164574099142402.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 328,473 Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000014 · wf-form4_164574099142402.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000014 · wf-form4_164574099142402.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,216 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 22:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-22-000014 · wf-form4_164574099142402.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000093 · wf-form4_163779741476619.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,501 Underlying: Common Stock · 7,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000093 · wf-form4_163779741476619.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,410 Underlying: Common Stock · 6,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000093 · wf-form4_163779741476619.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,626 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 11,287 | $4.49 | $50,678.63 |
DisclosureSEC source: 0001162194-21-000093 · wf-form4_163779741476619.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,224 Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000093 · wf-form4_163779741476619.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000093 · wf-form4_163779741476619.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,789 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 23:44 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000093 · wf-form4_163779741476619.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000080 · wf-form4_162984658299923.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,223 Underlying: Common Stock · 7,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000080 · wf-form4_162984658299923.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,292 Underlying: Common Stock · 6,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000080 · wf-form4_162984658299923.xml · derivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,439 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 11,287 | $6.53 | $73,704.11 |
DisclosureSEC source: 0001162194-21-000080 · wf-form4_162984658299923.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,094 Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000080 · wf-form4_162984658299923.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,381 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000080 · wf-form4_162984658299923.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,659 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 23:10 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000080 · wf-form4_162984658299923.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,795 shares purchased on May 28, 2021 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 155,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · derivative · entry 9 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,000 Underlying: Common Stock · 155,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On May 23, 2020, the Reporting Person was granted 310,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. F5 · derivative.expiration_date: On May 23, 2020, the Reporting Person was granted 310,000 Restricted Stock Units vesting as to 1/2 of the total number of shares on May 20, 2021, and as to 1/4th of the total number of shares on each of May 20, 2022 and May 20, 2023. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · derivative · entry 8 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,945 Underlying: Common Stock · 7,722 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,174 Underlying: Common Stock · 6,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F3 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F3 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,252 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 89,329 | $5.52 | $493,096.08 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · nonDerivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,169 Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 155,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 380,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,498 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 20:09 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000045 · wf-form4_162188694955372.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,894 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 20, 2021 Filed Apr 22, 2021 22:30 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 186,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000028 · wf-form4_161913058097227.xml · derivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,667 Underlying: Common Stock · 186,667 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F2 · derivative.exercise_date: Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter. F2 · derivative.expiration_date: Restricted Stock Units vest as to 1/4 of the underlying shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 30,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · derivative · entry 10 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,667 Underlying: Common Stock · 30,888 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F7 · derivative.exercise_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. F7 · derivative.expiration_date: On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · derivative · entry 9 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,056 Underlying: Common Stock · 6,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F6 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F6 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · derivative · entry 8 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,065 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 3,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 57,705 | $6.12 | $353,154.60 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · nonDerivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,081 Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 64,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · nonDerivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,786 F2 · shares: Represents shares acquired as a result of the certification of the performance condition for performance-based Restricted Stock Units granted on March 19, 2018. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 30,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2021 Filed Feb 24, 2021 02:57 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 3,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-21-000006 · wf-form4_161413540879138.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 2,080 shares purchased on November 30, 2020 under the Company's 2017 Employee Stock Purchase Plan. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 22:22 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | SaleCommon Stock | 84,820 | $6.06 | $514,009.20 |
DisclosureSEC source: 0001162194-20-000115 · wf-form4_160625655692240.xml · nonDerivative · entry 5 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,347 F1 · kind: The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 14, 2020. F2 · price: The range of prices for the transactions reported is between $6.28 and $5.925 per share. $6.06 represents the weighted average sale price per share. The Reporting Person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:22 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000115 · wf-form4_160625655692240.xml · derivative · entry 8 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,938 Underlying: Common Stock · 6,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F6 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F6 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:22 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000115 · wf-form4_160625655692240.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,878 Underlying: Common Stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:22 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000115 · wf-form4_160625655692240.xml · derivative · entry 6 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,167 Underlying: Common Stock · 4,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F4 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. F4 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 76,000 Restricted Stock Units vesting as to 1/12th of the total number of shares on May 20, 2017, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:22 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 9,791 | $6.28 | $61,487.48 |
DisclosureSEC source: 0001162194-20-000115 · wf-form4_160625655692240.xml · nonDerivative · entry 4 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,167 Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:22 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000115 · wf-form4_160625655692240.xml · nonDerivative · entry 3 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:22 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000115 · wf-form4_160625655692240.xml · nonDerivative · entry 2 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,076 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:22 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000115 · wf-form4_160625655692240.xml · nonDerivative · entry 1 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 23:20 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 6,882 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-20-000101 · wf-form4_159831118572332.xml · derivative · entry 7 Linthwaite Stephen Christopher · CIK 0001680808 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,820 Underlying: Common Stock · 6,882 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. F5 · derivative.exercise_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. F5 · derivative.expiration_date: On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.